Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -6.84%226.69M | -1.90%223.72M | 5.57%229.34M | 10.04%918.36M | 8.87%229.74M | 18.11%243.33M | 10.20%228.05M | 3.16%217.24M | 3.73%834.58M | 2.33%211.02M |
| Operating revenue | -11.37%152.47M | -4.61%148.56M | 3.89%144.61M | 14.18%617.9M | 8.99%150.93M | 27.18%172.03M | 16.21%155.74M | 4.36%139.2M | 3.29%541.14M | 4.23%138.48M |
| Cost of revenue | -15.78%85.35M | -13.14%82.37M | 6.98%92.55M | 15.52%370.85M | 6.77%88.16M | 34.03%101.35M | 23.05%94.83M | 0.86%86.51M | 6.30%321.02M | 7.13%82.57M |
| Gross profit | -0.45%141.34M | 6.10%141.35M | 4.63%136.79M | 6.61%547.51M | 10.22%141.58M | 8.88%141.98M | 2.57%133.22M | 4.73%130.73M | 2.18%513.56M | -0.54%128.45M |
| Operating expense | -3.17%8.8M | -2.86%8.93M | 22.41%10.53M | 3.58%37.67M | 2.39%10.79M | 17.10%9.09M | -1.34%9.19M | -1.74%8.6M | 9.32%36.37M | 35.33%10.54M |
| Selling and administrative expenses | -3.29%8.47M | -2.97%8.59M | 23.32%10.2M | 3.72%36.34M | 2.46%10.46M | 17.88%8.76M | -1.39%8.86M | -1.81%8.27M | 9.71%35.04M | 36.92%10.21M |
| -General and administrative expense | -3.29%8.47M | -2.97%8.59M | 23.32%10.2M | 3.72%36.34M | 2.46%10.46M | 17.88%8.76M | -1.39%8.86M | -1.81%8.27M | 9.71%35.04M | 36.92%10.21M |
| Depreciation amortization depletion | 0.00%332K | 0.00%333K | 0.00%333K | 0.00%1.33M | 0.30%333K | -0.30%332K | 0.00%333K | 0.00%333K | -0.08%1.33M | -0.30%332K |
| -Depreciation and amortization | 0.00%332K | 0.00%333K | 0.00%333K | 0.00%1.33M | 0.30%333K | -0.30%332K | 0.00%333K | 0.00%333K | -0.08%1.33M | -0.30%332K |
| Operating profit | -0.27%132.54M | 6.76%132.42M | 3.38%126.26M | 6.84%509.84M | 10.92%130.79M | 8.36%132.89M | 2.87%124.03M | 5.22%122.13M | 1.67%477.19M | -2.84%117.91M |
| Net non-operating interest income (expenses) | -0.55%-44.58M | -4.85%-43.73M | -5.27%-42.77M | -17.28%-169M | -12.86%-42.33M | -20.07%-44.34M | -19.22%-41.71M | -17.15%-40.63M | -8.65%-144.09M | -7.64%-37.51M |
| Non-operating interest income | -3.41%3.26M | -20.34%3.07M | -17.55%3.27M | -28.69%14.21M | -31.80%3.02M | -36.78%3.37M | -26.69%3.85M | -19.24%3.97M | 7.76%19.93M | -20.91%4.42M |
| Non-operating interest expense | 0.25%46.79M | 2.60%45.76M | 3.07%44.98M | 11.81%179.2M | 8.09%44.29M | 13.00%46.67M | 13.43%44.6M | 12.81%43.64M | 8.65%160.28M | 3.50%40.97M |
| Total other finance cost | 1.06%1.05M | 8.22%1.04M | 10.95%1.06M | 7.07%4.02M | 10.44%1.06M | 8.14%1.04M | 4.34%961K | 5.04%959K | 3.99%3.75M | 12.44%958K |
| Other net income (expenses) | 84.98%-6.92M | -56.01%20.5M | 9.35%-93.07M | -127.55%-48.77M | 180.61%53.39M | -135.59%-46.08M | -43.40%46.59M | -426.23%-102.67M | -40.85%177.01M | -580.15%-66.24M |
| Gain on sale of security | 81.42%-9.14M | -22.85%26.74M | 4.05%-94.65M | -168.11%-69.36M | 178.06%43.82M | -173.36%-49.2M | -49.67%34.67M | -547.77%-98.64M | -65.29%101.84M | -503.58%-56.13M |
| Income before tax | 90.77%81.04M | -15.30%109.19M | 54.75%-9.58M | -42.74%292.07M | 901.41%141.85M | -80.26%42.48M | -23.22%128.92M | -118.76%-21.18M | -19.79%510.1M | -85.88%14.17M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 90.77%81.04M | -15.30%109.19M | 54.75%-9.58M | -42.74%292.07M | 901.41%141.85M | -80.26%42.48M | -23.22%128.92M | -118.76%-21.18M | -19.79%510.1M | -85.88%14.17M |
| Net income continuous operations | 90.77%81.04M | -15.30%109.19M | 54.75%-9.58M | -42.74%292.07M | 901.41%141.85M | -80.26%42.48M | -23.22%128.92M | -118.76%-21.18M | -19.79%510.1M | -85.88%14.17M |
| Noncontrolling interests | 90.43%15.37M | -15.14%20.68M | 55.89%-1.72M | -42.62%55.32M | 870.11%26.78M | -80.13%8.07M | -23.14%24.37M | -118.27%-3.9M | -19.61%96.4M | -85.44%2.76M |
| Net income attributable to the company | 90.85%65.67M | -15.34%88.51M | 54.50%-7.86M | -42.77%236.76M | 908.99%115.08M | -80.29%34.41M | -23.24%104.55M | -118.88%-17.28M | -19.83%413.7M | -85.98%11.41M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 90.85%65.67M | -15.34%88.51M | 54.50%-7.86M | -42.77%236.76M | 908.99%115.08M | -80.29%34.41M | -23.24%104.55M | -118.88%-17.28M | -19.83%413.7M | -85.98%11.41M |
| Diluted earnings per share | 90.71%0.3852 | -15.41%0.5192 | 54.53%-0.0461 | -42.80%1.3897 | 908.54%0.6755 | -80.30%0.202 | -19.71%0.6137 | -118.88%-0.1015 | -19.86%2.4294 | -85.99%0.067 |
| Basic earnings per share | 90.71%0.3852 | -15.41%0.5192 | 54.53%-0.0461 | -42.80%1.3897 | 908.54%0.6755 | -80.30%0.202 | -18.87%0.6137 | -118.88%-0.1015 | -19.86%2.4294 | -85.99%0.067 |
| Dividend per share | 0.00%0.4625 | 0.00%0.4625 | 0.00%0.4625 | 0.00%1.85 | 0.00%0.4625 | 0.00%0.4625 | 0.00%0.4625 | 0.00%0.4625 | 0.00%1.85 | 0.00%0.4625 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.